₹6,526.00
+₹33.50 (+0.52%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹19,092 Cr
P/E
23.54
ROE
10.90%
ROCE
14.31%
About Atul Ltd
Atul is mainly in the business of Life Science Chemicals and Performance and Other Chemicals and caters to the needs of varied industries across the world such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Flavour, Food, Footwear, Fragrance, Glass, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Polymer, Rubber, Soap and Detergent, Sport and Leisure, Textile, Tyre and Wind Energy.
Founded
1975
CEO
Sunil S Lalbhai
Employees
6,323
HQ
Valsad, India
About Atul Ltd
Atul is mainly in the business of Life Science Chemicals and Performance and Other Chemicals and caters to the needs of varied industries across the world such as Adhesives, Agriculture, Animal Feed, Automobile, Composites, Construction, Cosmetic, Defence, Dyestuff, Electrical and Electronics, Flavour, Food, Footwear, Fragrance, Glass, Home Care, Horticulture, Hospitality, Paint and Coatings, Paper, Personal Care, Pharmaceutical, Plastic, Polymer, Rubber, Soap and Detergent, Sport and Leisure, Textile, Tyre and Wind Energy.
Founded:1975
CEO:Sunil S Lalbhai
Employees:6,323
HQ:Valsad, India
Finished Products
1Sale of Products
₹5,384.96Cr2Service Charges
₹109.57Cr3Others
₹56.23Cr4Scrap
₹12.81CrRaw Materials
1Raw Material Consumed
₹5,690.90Cr2Finished Goods Purchases
₹79.39Cr3Purchase
₹57.00CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹7,180
52W Low
₹5,561
Volume23.38K
Avg VolumeN/A
Beta0.65
Dividend Yield0.46%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
23.54x
Valuation
P/B Ratio
3.07x
Valuation
EPS
₹275.44
Valuation
Dividend Yield
0.46%
Valuation
ROE
10.90%
Profitability
ROCE
14.31%
Profitability
Revenue by Segment
Contribution & growth by business line
Performance and Other Chemicals
+18.0%68.4%
₹3,818.01 Cr
Life Science Chemicals
+18.6%30.3%
₹1,691.42 Cr
Others
+16.9%1.3%
₹73.92 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
59.6%
International
40.4%
In India59.6%
Outside India40.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
A
Astrazeneca Holdings BV
Netherland
0.77% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
9.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.